The value of routine BMD monitoring after starting bisphosphonate treatment
J Bone Miner Res
.
2010 Jan;25(1):173-4.
doi: 10.1359/jbmr.091111.
Authors
Katy J L Bell
,
Andrew Hayen
,
Les Irwig
,
Petra Macaskill
,
Jonathan C Craig
,
Kristine E Ensrud
,
Douglas C Bauer
PMID:
19929431
DOI:
10.1359/jbmr.091111
No abstract available
Publication types
Comment
Letter
MeSH terms
Bone Density / physiology*
Diphosphonates / therapeutic use*
Fractures, Bone / drug therapy
Humans
Monitoring, Physiologic*
Patient Compliance
Randomized Controlled Trials as Topic
Risk Factors
Substances
Diphosphonates